Dr. Laheru currently serves as an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Laheru specializes in gastrointestinal oncology with a specific focus in pancreatic cancer. His clinical research interests are in developing and testing new therapies for the treatment of pancreatic cancer. He has developed a clinical trial program to optimize a vaccine approach using GM-CSF transfected pancreatic cell lines as a vaccine in two distinct patient populations. He has also incorporated correlative studies that should provide important information to better understand optimal vaccine boosting schedules as well as to identify antigens that can be predictive in-vitro markers for anti-tumor immune responses. Dr. Laheru is investigating mechanisms of chemotherapy resistance in pancreatic cancer and will be developing and testing new targets for therapy in patients with metastatic pancreas cancer.


1990 Honors B.A., Magna Cum Laude in Chemistry-The University of Utah
1995 M.D., The Baylor College of Medicine- Houston, Texas 77054
1995-96 Intern in Internal Medicine-The University of Utah Hospital and Clinics
1996-98 Resident in Internal Medicine-The University of Utah Hospital and Clinics
1998-2001 Clinical Fellow in Medical Oncology- The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center

Board Certifications and Certificates

American Board of Internal Medicine-1998
Medical Oncology-2000

Clinical Interests

Pancreatobiliary Cancer, Colorectal Cancer

View complete profile


Dan A. Laheru, M.D.
Johns Hopkins Oncology Center
1650 Orleans Street
Buntings Blaustein Cancer Research Building, Rm 4M09
Baltimore, MD, 21231 USA
Work 410-955-8974
Fax 410-614-9334